Obesity Isn’t A Willpower Problem: The Role Of GLP-1s | Dr. Spencer Nadolsky

The Dr. Tyna Show

Dr. Tyna Moore

Alternative Health, Health & Fitness

4.9 • 1.4K Ratings

🗓️ 15 May 2025

⏱️ 67 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

EP. 212: Today I’m joined by Dr. Spencer Nadolsky, obesity specialist, Lipidologist, and founder of Vineyard, a cutting-edge direct care platform. We’re diving deep into the conversation you’ve been asking for: the real story behind GLP-1s, obesity as a chronic disease, and why treating it goes far beyond weight loss. We break down everything from proper dosing, common side effects, and the dangers of vanity prescribing to the systemic issues with telemedicine and PBMs. Dr. Nadolsky and I also discuss strength training, preserving muscle mass, and how GLP-1s may support metabolic and cardiovascular health beyond their FDA indications. This episode cuts through the noise and misinformation. If you care about metabolic health, this one’s essential. Topics Discussed: What are the real benefits of GLP-1 medications beyond weight loss? Is obesity truly a chronic disease, and how should it be treated? What are the risks of GLP-1 vanity dosing and fast titration? How do GLP-1s impact muscle mass and metabolic health? Why are telemedicine and PBMs problematic for obesity treatment? Sponsored By: Maui Nui Venison | Head to mauinuivenison.com/DRTYNA to secure your access now. LMNT | Get your free Sample Pack with any LMNT purchase at drinkLMNT.com/drtyna Qualia | Go to qualialife.com/DRTYNA for up to 50% off your purchase and use code DRTYNA for an additional 15% Liver Love | Go to https://store.drtyna.com/products/liverlove Use code LIVER20 for 20% off On This Episode We Cover: 00:00:00 – Introduction 00:02:48 – GLP-1 Dosing 00:06:35 – Side Effects of Vanity Dosing 00:08:51 – Reducing GLP-1 Dosing 00:12:27 – Med Spas & Telemedicine Risks 00:14:20 – Slow Titration for Better Tolerance 00:18:44 – Pharma Profits & Overdosing 00:20:49 – Obesity Treatment Pre & Post GLP-1s 00:27:58 – Obesity Is a Chronic Disease 00:32:45 – Defining obesity 00:36:16 – The Role of Genetics in Obesity 00:38:59 – Lifestyle Factors Beyond Genetics 00:40:46 – Insurance Barriers & PBM Costs 00:44:37 – Anti-GLP-1 Bias in Healthcare 00:46:22 – Why Strength Training Matters 00:51:39 – New Doctors & Role of AI 00:53:38 – Protecting Muscle on GLP-1s 00:58:55 – No Shortcuts to Health 01:02:01 – The Vineyard Show Links: Glp-1s Can Help Employers Lower Medical Costs In 2 Years, New Study Finds Further Listening GLP1 Uncovered FREE 4 Part Video Series Ozempic Done Right Playlist EP. 202 | The Fight for Affordable GLP1s & the Truth About Big Pharma | Dave Knap Check Out Dr. Spencer Vineyard Instagram Website Podcast Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.

Transcript

Click on a timestamp to play from that location

0:00.0	I was so ravenously hungry and craving.
0:03.1	And what my patients described was kind of that.
0:05.6	So I could imagine them being, you know, in a 300 pound or 250 pound body with a lot of
0:10.6	excess adipose tissue, trying to lose weight.
0:13.3	And feeling that way, just that, you know, I was already really lean, but like they're
0:17.5	feeling that way at a higher body fat.
0:19.7	That's what made me go like,
0:21.4	oh, man, I think I missed the mark. You are tuned into the Dr. Tina show with Dr. Tina more.
0:27.5	For more, visit Dr. Tina.com. On this episode of the Dr. Tina show, I'm so excited to bring on
0:34.1	Dr. Spencer Nodalski. Dr. Nodalski is someone I've been following for a long time on
0:39.1	Instagram. He's an obesity specialist. He's a lipidologist. He also is the owner and founder
0:44.1	of Vineyard, which is an online direct care model. He specializes in GLP-1s and we are going
0:51.2	to have the obesity conversation that you all have been asking me for.
0:54.9	You know I've been talking about these peptides for a long time outside of weight loss,
0:58.9	outside of type 2 diabetes, although my message has been skewed over the past few years.
1:03.6	I've been trying to talk about them in relation to all of the other benefits throughout the
1:07.8	body that they may or may not have in the clinical data.
1:12.4	That said, this is an important conversation to have. We need to talk about obesity as a disease,
1:17.1	and I need folks to really understand what that means, and I can't think of a better person
1:21.9	for the job than Dr. Nodalski. So without further ado, let's jump in. Dr. Spencer Nodalski, I'm so excited to have you on the Dr.
1:29.7	Tina show today. And we are going to talk all things, obesity, gLP ones. This is a conversation I wanted
1:35.5	to have because I've been trying to sing the praises of gLP1 agonists outside of obesity and weight
	...

Transcript will be available on the free plan in 16 days. Upgrade to see the full transcript now.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Dr. Tyna Moore, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Dr. Tyna Moore and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.